Corrigendum to “Cilengitide inhibits osteoclast adhesion through blocking the αvβ3-mediated FAK/Src signaling pathway” [Heliyon 9(7) (July 2023) e17841]

• Dan-yang Guo,
• Zhong-hua Chen,
• Yi-fei Fu,
• Yue-yue Li,
• Meng-nan Chen,
• Jun-jie Wu,
• Zheng-dong Yuan,
• Jun-Xing Ye,
• Xia Li,
• Feng-lai Yuan

Affiliations

Dan-yang Guo

Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214041, China

Zhong-hua Chen

Fuyang Hospital of Anhui Medical University, Fuyang, Anhui, 236, China

Yi-fei Fu

Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214041, China

Yue-yue Li

Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214041, China

Meng-nan Chen

Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214041, China

Jun-jie Wu

Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214041, China

Zheng-dong Yuan

Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214041, China

Jun-Xing Ye

Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214041, China

Xia Li

Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214041, China

Feng-lai Yuan

Institute of Integrated Chinese and Western Medicine, Affiliated Hospital of Jiangnan University, Wuxi, Jiangsu, 214041, China; Corresponding author.